| 
			
			 DEATHS 
			AND INFECTIONS * Eikon users, see COVID-19: MacroVitals
			
			https://apac1.apps.cp. thomsonreuters.com/
 cms/?navid=1592404098 for a case tracker and summary of news.
 
 EUROPE
 
 * Russia has extended a ban on flights to and from Britain until the 
			end of March 16 due to a new variant of the coronavirus first 
			detected in the UK, Russia's coronavirus taskforce said.
 
 * The Dutch government's coronavirus policy was dealt a serious blow 
			when a court ordered it to scrap a controversial night-time curfew 
			meant to limit the spread of COVID-19.
 
 * The first 550,000 doses of the Sinopharm vaccine have arrived in 
			Budapest, a leading health official said, as Hungary prepares to 
			become the first EU country to roll out the Chinese shot.
 
			
			 
			
 * Britain will provide vaccine COVID-19 certificates for its 
			residents if they are required by other countries, although it is 
			not planning to introduce them for use at home, vaccines minister 
			Nadhim Zahawi said.
 
 * Germany plans to offer all citizens rapid coronavirus tests free 
			of charge from March 1, its health minister said.
 
 * The COVID-19 pandemic is on the rise again in Poland, the health 
			minister said, a worrying turnaround after case numbers stabilised 
			following a second wave of infections last autumn.
 
 AMERICAS
 
 * U.S. President Joe Biden will travel to Wisconsin to press his 
			case for a $1.9 trillion pandemic relief bill in the political 
			battleground state that helped secure his victory in last year's 
			election.
 
 ASIA-PACIFIC
 
 * South Korea's intelligence agency has said North Korea attempted 
			to steal information on coronavirus vaccines and treatments by 
			hacking Pfizer, a lawmaker briefed by the agency said.
 
 * India has detected both the South African and Brazilian 
			coronavirus variants and people returning from those countries may 
			be tested more aggressively, health officials said.
 
 * Hong Kong will ease strict restrictions from Feb. 18, re-opening 
			sports and entertainment facilities and extending dining hours, 
			Health Secretary Sophia Chan said, while the government advisory 
			panel on COVID-19 vaccines said it would recommend China's Sinovac 
			vaccine for emergency use.
 
			
            [to top of second column] | 
			
			 
			* Malaysia will receive its first batch of Pfizer-BioNTech vaccines 
			over the weekend for a COVID-19 inoculation drive that is set to 
			begin on Feb. 26, the prime minister said.
 MIDDLE EAST AND AFRICA
 
 * Turkey is considering a plan to ease some curfews and curbs on 
			restaurants and schools in districts where infections are lightest, 
			and the cabinet is set to discuss possible details on Wednesday, two 
			officials told Reuters.
 
 * South Africa wants to return the one million COVID-19 vaccine 
			doses it has received from Serum Institute of India, The Economic 
			Times reported, a week after the country said it would put on hold 
			use of AstraZeneca's shot in its vaccination program.
 
 MEDICAL DEVELOPMENTS
 
 * The World Health Organization listed AstraZeneca's COVID-19 
			vaccine for emergency use, while sources said the EU is in talks 
			with Moderna on buying more vaccines.
 
 * Australia's medical regulator granted provisional approval for the 
			AstraZeneca vaccine.
 
 * The European Union will this week kick off a new programme to 
			study mutations in the COVID-19 virus, the European Commission's 
			president told Les Echos.
 
 ECONOMIC IMPACT
 
 * Global shares hit record highs on Tuesday and were on track for 
			their longest winning streak in 17 years as investors bet the 
			roll-out of COVID-19 vaccines would lead to a durable economic 
			recovery and draw a line under a year of lockdowns.
 
			
			 
			* Singapore will set aside a further S$11 billion in a COVID-19 
			support package this year, its finance minister said, extending last 
			year's unprecedented fiscal response to the pandemic.
 (Compiled by Jagoda Darlak and Devika Syamnath; Editing by Giles 
			Elgood)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content |